BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22018687)

  • 1. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam.
    Manna SS; Umathe SN
    Brain Res; 2011 Nov; 1425():75-82. PubMed ID: 22018687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible participation of transient receptor potential vanilloid type 1 channels in the antidepressant effect of fluoxetine.
    Manna SS; Umathe SN
    Eur J Pharmacol; 2012 Jun; 685(1-3):81-90. PubMed ID: 22542657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antidepressant- and anxiolytic-like activity of α-spinasterol, a plant derivative with TRPV1 antagonistic effects, in mice.
    Socała K; Wlaź P
    Behav Brain Res; 2016 Apr; 303():19-25. PubMed ID: 26808607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
    Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ; Stern CA; Bertoglio LJ
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J; Di Marzo V; Brotchie JM
    Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QX-314 produces long-lasting local anesthesia modulated by transient receptor potential vanilloid receptors in mice.
    Ries CR; Pillai R; Chung CC; Wang JT; MacLeod BA; Schwarz SK
    Anesthesiology; 2009 Jul; 111(1):122-6. PubMed ID: 19512885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Umathe SN; Manna SS; Utturwar KS; Jain NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
    Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
    Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor.
    Umathe SN; Manna SS; Jain NS
    Neuropharmacology; 2012 Apr; 62(5-6):2024-33. PubMed ID: 22248639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors.
    de Man JG; Boeckx S; Anguille S; de Winter BY; de Schepper HU; Herman AG; Pelckmans PA
    Neurogastroenterol Motil; 2008 May; 20(5):546-56. PubMed ID: 18194153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.
    Wang L; Wang DH
    Circulation; 2005 Dec; 112(23):3617-23. PubMed ID: 16314376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
    Umathe SN; Bhutada PS; Jain NS; Shukla NR; Mundhada YR; Dixit PV
    Neuropeptides; 2008 Aug; 42(4):399-410. PubMed ID: 18533256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient receptor potential vanilloid receptor 1, TRPV1 (VR1) inhibits peristalsis in the mouse jejunum.
    Rahmati R
    Arch Iran Med; 2012 Jul; 15(7):433-8. PubMed ID: 22724881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures.
    Manna SS; Umathe SN
    Epilepsy Res; 2012 Jun; 100(1-2):113-24. PubMed ID: 22386872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.